Johnson & Johnson said on Thursday the U.S. Food and Drug Administration had approved its antibody-based therapy for patients with a difficult-to-treat type of blood cancer.
Johnson & Johnson said on Thursday the U.S. Food and Drug Administration had approved its antibody-based therapy for patients with a difficult-to-treat type of blood cancer.
we’ll die of preventable and curable illnesses to own the libs
@PrefersAwkward @Burn_The_Right
Ofc you will 'cause that’s what Jesus would have done.